Using super-high magnification dermoscopy to diagnose skin tumors
Part of Cancer, Skin clinical trials.
This trial tests whether a special, very high-magnification dermoscopy tool can help doctors better diagnose skin tumors. It may improve accuracy during routine skin cancer screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be 18 years or older.
- You must be willing to have a skin cancer screening with dermoscopy.
- You need to be able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of marking skin before removing a non-melanoma skin cancer: using a special magnifying tool called a dermoscope versus the standard method. The goal is to see which method helps remove the cancer completely the first time.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
This trial tests a new device (Dermalyser) that estimates how thick a suspected melanoma is by analyzing a dermoscopy image. It may help doctors plan surgery without needing extra procedures.
This trial uses a special optical imaging scan to help diagnose skin cancer without needing a biopsy. It may be a good option if you have a suspicious skin lesion.
This trial tests an at-home/clinic skin-scanning method (using light) to look for signs of melanoma, basal cell cancer, or squamous cell cancer. You may be able to help researchers see whether this non-invasive “virtual biopsy” can guide diagnosis, especially in people with different skin types.
This trial uses a special microscope to look at skin biopsy samples in new ways. It may help doctors understand skin conditions better without needing extra procedures.
Hear when a new Skin Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.